Nanosene (Pty) Ltd is the first bespoke polymer supplier from Africa that focuses on developing and producing amphiphilic polymers to isolate molecular drug targets. This breakthrough technology can transform the world of medicine by empowering researchers and drug developers to explore new avenues for treating various diseases.
For researchers and drug developers to create and discover new therapeutics to treat diseases such as obesity, depression or even cancer, they need to study and understand proteins embedded in the cell membrane. These membrane proteins play an essential role in regulating physiological processes, therefore considered prime therapeutic targets for nearly 70% of FDA-approved drugs.
Nanosene’s technology produces polymers that act as indispensable tools for the solubilisation of intact and functional membrane proteins in nanoscale discs. This nanodisc technology offers researchers the unprecedented opportunity to access some of the most valued proteins in a biologically active state.Our team of skilled and knowledgeable scientists is dedicated to offering top-notch guidance and services to our clients, helping them achieve their research objectives and contribute to the advancement of therapeutic design.